Ventana Medical Systems, Inc. C4d 760-4436

Description
C4d is a stable split product remnant of classical complement activation which becomes covalently bound to endothelium and basement membrane, after induction of the classical antibody-induced pathway. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in both chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival and is therefore an aid in treating acute rejection.
Description
C4d is a stable split product remnant of classical complement activation which becomes covalently bound to endothelium and basement membrane, after induction of the classical antibody-induced pathway. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in both chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival and is therefore an aid in treating acute rejection.

Suppliers

Company
Product
Description
Supplier Links
C4d is a stable split product remnant of classical complement activation which becomes covalently bound to endothelium and basement membrane, after induction of the classical antibody-induced pathway. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in both chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival and is therefore an aid in treating acute rejection.

C4d is a stable split product remnant of classical complement activation which becomes covalently bound to endothelium and basement membrane, after induction of the classical antibody-induced pathway. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in both chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival and is therefore an aid in treating acute rejection.

Supplier's Site

Technical Specifications

  Ventana Medical Systems, Inc.
Product Category Organic Chemicals
Product Number 760-4436
Product Name C4d
Unlock Full Specs
to access all available technical data

Similar Products

AsahiKlin Precision Cleaning Solvent - AE3100E - AGC Chemicals Americas, Inc.
Specs
Trigger Solvent
Chemical Family All Halogenated; All Ethers; Ethanol
Chemical Name 1,1,2,2- tetra fluoroethyl-2,2,2- trifluoro ethyl ether
View Details
DMI 1,3 Dimethyl-2-Imidazolidinone -  - Mitsui Chemicals America, Inc.
Mitsui Chemicals America, Inc.
Specs
Trigger Solvent
Chemical Name DMI 1,3 Dimethyl-2-Imidazolidinone
State of Matter Liquid / Solution
View Details
Solvents -  - Esprix Technologies
Esprix Technologies
Specs
Trigger Solvent
Chemical Name DMSO, NMP, TMAH, MEA, N-aminopropylmorpholine, Butyldiglycol
View Details
Calcitonin - 760-2611 - Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc.
View Details